Isodiol International Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ISOLF research report →
Companyisodiol.com
Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds.
- CEO
- Marcos Agramont
- IPO
- 2014
- HQ
- Vancouver, BC, CA
Price Chart
Valuation
- Market Cap
- $4.91K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.07
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -24.35%
- Op Margin
- -175.52%
- Net Margin
- -542.13%
- ROE
- -427.45%
- ROIC
- -243.37%
Growth & Income
- Revenue
- $16.65M · 12.19%
- Net Income
- $-90,282,899 · -223.14%
- EPS
- $-2.35 · -76.69%
- Op Income
- $-29,229,739
- FCF YoY
- 9.90%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.20
- Avg Volume
- 7.24K
Get TickerSpark's AI analysis on ISOLF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ISOLF Coverage
We haven't published any research on ISOLF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ISOLF Report →